PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15991021-6	2005	Skeletal muscle adipoR1 expression was down-regulated from 109.0 (70.1-165.7) (median [interquartile range]) to 82.8 (63.6-89.3) relative units (p=0.04), but adipose tissue adipoR1 expression was up-regulated from 5.3 (4.4-9.4) to 11.2 (4.8-15.3) relative units (p=0.02) by rosiglitazone.	Rosiglitazone	274-287	adiponectin receptor 1	Homo sapiens	16-23	
24178343-7	2013	Rosiglitazone increased serum adiponectin concentration and the expression levels of adiponectin and adipoR1 (P < 0.05), while dexamethasone had the opposite effect.	Rosiglitazone	0-13	adiponectin receptor 1	Homo sapiens	101-108	
15991021-8	2005	The increase in adipose tissue adipoR1 expression with rosiglitazone was associated with increased postprandial triglyceride clearance (r=0.67, p=0.05), and increased fasting fatty acid output (r=0.78, p=0.01) measured in subcutaneous adipose tissue.	Rosiglitazone	55-68	adiponectin receptor 1	Homo sapiens	31-38	
15991021-9	2005	CONCLUSIONS/INTERPRETATION: AdipoR1 expression is up-regulated in adipose tissue but down-regulated in skeletal muscle by rosiglitazone.	Rosiglitazone	122-135	adiponectin receptor 1	Homo sapiens	28-35